Cargando…
Blinded Independent Central Review (BICR) in New Therapeutic Lung Cancer Trials
SIMPLE SUMMARY: Lung cancer treatment has dramatically evolved in the past decade, but some pitfalls of image interpretation have been introduced in parallel, such as pseudo-progressions. These challenges could be made more evident with blinded independent central reviews, as readers are often blind...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465869/ https://www.ncbi.nlm.nih.gov/pubmed/34572761 http://dx.doi.org/10.3390/cancers13184533 |